ARCHIVES

In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th

This article is from The Cancer Letter archive.

Vol. 10 No. 30 | July 27, 1984

Download PDF Visit The Full Archive

Related Articles

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings.

August 8, 2008

Howard Hughes Medical Institute Appoints 12 Physician Investigators

May 31, 2002

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

January 25, 2008

Et2’s Referral Guidelines

July 23, 1993

International Group Plans Survey On Thrombosis Risk

July 27, 2001